Chronic Wasting Disease in Deer: Prion Pathology and Surveillance in Wildlife Populations

Introduction

Chronic wasting disease (CWD) is a fatal, progressive neurodegenerative disorder affecting members of the family Cervidae, including white-tailed deer (Odocoileus virginianus), mule deer (Odocoileus hemionus), elk (Cervus canadensis), and moose (Alces alces). CWD is classified as a transmissible spongiform encephalopathy (TSE) and is caused by the accumulation of a misfolded, protease-resistant isoform (PrP^Sc) of the host-encoded cellular prion protein (PrP^C). Unlike conventional infectious agents such as viruses or bacteria, prions lack nucleic acids and propagate through conformational templating. This places CWD within the category of unconventional infectious agents, often discussed alongside parasitic entities due to their unique biological transmission mechanisms and environmental persistence [1, 2].

CWD was first recognized in captive mule deer in Colorado and Wyoming in the late 1960s and has since spread across North America, with detections in Canada, South Korea, and Scandinavia [3, 4]. The disease poses significant challenges for wildlife management, conservation, and cervid farming due to its long incubation period, environmental stability, and lack of effective treatments or vaccines. This article provides an exhaustive review of CWD prion pathology, clinical presentation, diagnostic methodologies, and surveillance frameworks essential for veterinary professionals and wildlife biologists.

Etiology and Prion Biology

The infectious agent in CWD is a misfolded conformer of the normal cellular prion protein (PrP^C). PrP^C is a glycophosphatidylinositol (GPI)-anchored membrane protein expressed predominantly in neurons and lymphoid tissues. The conversion of PrP^C to PrP^Sc involves a structural transition from a predominantly alpha-helical conformation to one rich in beta-sheet content, conferring resistance to proteolysis and promoting aggregation [5, 6]. PrP^Sc acts as a template, inducing further conversion of PrP^C in a autocatalytic cascade.

The molecular mechanisms underlying prion propagation involve nucleation-polymerization kinetics. Small aggregates (oligomers) of PrP^Sc serve as seeds that recruit and misfold additional PrP^C monomers, leading to fibril elongation and eventual fragmentation, which generates new seeds [7, 8]. This process is central to the exponential amplification observed in vitro using techniques such as real-time quaking-induced conversion (RT-QuIC).

Strain diversity in CWD has been documented, with multiple prion strains exhibiting distinct biochemical properties, incubation periods, and tropism for lymphoid versus neural tissues [9, 10]. Strain variation is encoded by conformational differences in PrP^Sc and is influenced by host prion protein gene (PRNP) polymorphisms. Polymorphisms at codon 96 (G96S) and codon 132 (M132L) in elk and at codon 225 (S225F) in white-tailed deer modulate susceptibility and incubation time [11, 12].

Clinical Signs and Pathology

CWD has a protracted incubation period ranging from 18 months to over 3 years. Clinical signs are insidious and progressive, reflecting the accumulation of PrP^Sc in the central nervous system (CNS) and peripheral lymphoid tissues. Affected animals exhibit behavioral changes, including listlessness, isolation from the herd, and reduced responsiveness to external stimuli [13]. Progressive weight loss (emaciation) despite normal appetite is a hallmark, giving the disease its name. Other signs include excessive salivation, polydipsia, polyuria, ataxia, head tremors, and teeth grinding (bruxism) [14, 15].

Pathologically, CWD is characterized by spongiform degeneration of the neuropil, neuronal vacuolation, astrogliosis, and microgliosis in specific brain regions, including the obex, thalamus, and hippocampus [16]. PrP^Sc deposits are detected by immunohistochemistry (IHC) as granular or plaque-like accumulations. In addition to CNS involvement, PrP^Sc accumulates in lymphoid tissues such as the retropharyngeal lymph nodes, palatine tonsils, and Peyer's patches, enabling antemortem diagnosis via biopsy [17, 18].

The following table summarizes the key clinical and pathological features of CWD in cervids:

Diagnostic Methods

Accurate diagnosis of CWD relies on detection of PrP^Sc in tissues or body fluids. Several diagnostic platforms are available, each with specific applications in surveillance and research.

Immunohistochemistry (IHC)

IHC is the gold standard for confirmatory diagnosis of CWD. Formalin-fixed, paraffin-embedded sections of the obex and retropharyngeal lymph node are treated with proteinase K to eliminate PrP^C, followed by incubation with monoclonal antibodies (e.g., F99/97.6.1) that bind PrP^Sc [19]. Visualization is achieved using chromogenic detection systems. IHC provides high specificity and allows assessment of PrP^Sc distribution and morphology. However, it is labor-intensive and requires specialized training.

Enzyme-Linked Immunosorbent Assay (ELISA)

ELISA-based methods are widely used for high-throughput screening of CWD in surveillance programs. These assays employ monoclonal antibodies that capture PrP^Sc after denaturation and proteolytic digestion. Commercial ELISA kits (generic term: commercial ELISA kits for prion detection) offer rapid turnaround and can be applied to brainstem and lymphoid tissue homogenates [20, 21]. Sensitivity and specificity exceed 95% in most validation studies, though false positives may occur in samples with low PrP^Sc levels. Positive ELISA results are typically confirmed by IHC or Western blot.

The principles of ELISA are analogous to those described for Feline Leukemia Virus p27 antigen detection, where antibody-antigen binding is quantified via enzymatic signal amplification.

Real-Time Quaking-Induced Conversion (RT-QuIC)

RT-QuIC is a highly sensitive in vitro amplification technique that detects prion seeding activity in tissues and body fluids. The assay uses recombinant PrP^C substrate, which is converted to amyloid fibrils in the presence of PrP^Sc seeds. Conversion is monitored in real time using thioflavin T fluorescence [22, 23]. RT-QuIC has demonstrated exceptional sensitivity for CWD detection in cerebrospinal fluid, nasal brushings, and rectal mucosa biopsies, enabling antemortem diagnosis [24, 25]. The assay can detect as few as 10 femtograms of PrP^Sc and is increasingly adopted for live-animal surveillance.

Western Blot

Western blot (immunoblotting) detects protease-resistant PrP^Sc after proteinase K digestion and electrophoretic separation. The characteristic three-band pattern (di-, mono-, and unglycosylated isoforms) confirms the presence of PrP^Sc [26]. Western blot is useful for strain typing based on molecular weight profiles and glycoform ratios.

Comparison of Diagnostic Methods

Surveillance Strategies

Surveillance for CWD in wildlife populations is essential for early detection, monitoring prevalence, and informing management interventions. Surveillance programs are typically stratified into passive and active components.

Passive Surveillance

Passive surveillance relies on testing of animals found dead, road-killed, or harvested by hunters. This approach is cost-effective and provides broad geographic coverage. However, it is biased toward clinically affected animals and may underestimate true prevalence [27]. Submission of heads or retropharyngeal lymph nodes from hunter-killed deer is a common passive surveillance method in North America.

Active Surveillance

Active surveillance involves targeted sampling of live or recently deceased animals from high-risk areas, such as captive facilities, game farms, or regions adjacent to known CWD-positive zones. Sampling may include rectal mucosa biopsies, tonsillar biopsies, or nasal brushings for RT-QuIC analysis [28]. Active surveillance provides more accurate prevalence estimates and enables detection of preclinical infections.

Spatial and Temporal Considerations

CWD distribution is heterogeneous, with clusters of high prevalence often associated with anthropogenic factors such as supplemental feeding, baiting, and captive cervid operations [29, 30]. Surveillance efforts should prioritize these high-risk areas and incorporate spatial modeling to identify corridors of potential spread. Temporal sampling during the hunting season and pre-calving periods can capture demographic variation.

The following Mermaid diagram illustrates a decision tree for CWD surveillance in wildlife populations:

flowchart TD
    A[Surveillance Objective], > B{Population Type}
    B, > C[Free-ranging]
    B, > D[Captive/Cervid Farm]
    C, > E[Passive: Hunter harvest, roadkill]
    C, > F[Active: Targeted sampling in high-risk zones]
    D, > G[Mandatory testing at death]
    D, > H[Live-animal testing for movement permits]
    E, > I[ELISA screening of lymph node/brain]
    F, > J[RT-QuIC on rectal mucosa or nasal brush]
    G, > I
    H, > J
    I, > K{ELISA Positive?}
    K, >|Yes| L[Confirm by IHC or Western blot]
    K, >|No| M[Report negative]
    L, > N{Confirmed CWD?}
    N, >|Yes| O[Implement management response]
    N, >|No| P[Investigate false positive]
    O, > Q[Quarantine, culling, movement restrictions]
    Q, > R[Enhanced surveillance]

Population Management

Management of CWD in wildlife populations is challenging due to the environmental persistence of prions and the difficulty of controlling animal movements. Strategies include:

• Culling and targeted removal: Reducing population density in endemic areas can lower transmission rates. Focused culling of infected social groups has been shown to reduce prevalence in some regions [31, 32].
• Bans on supplemental feeding and baiting: These practices concentrate animals and increase direct and indirect contact, facilitating prion transmission via saliva, feces, and urine [33].
• Movement restrictions: Regulations on the transport of live cervids and carcasses help prevent geographic spread. Many jurisdictions require testing of captive cervids before interstate movement [34].
• Environmental decontamination: Prions are resistant to conventional disinfection methods. Incineration, alkaline hydrolysis, and exposure to 2N sodium hydroxide are effective for contaminated materials [35]. Soil remediation remains an area of active research.
• Genetic selection: Breeding programs in captive herds may select for PRNP genotypes associated with reduced susceptibility, though this approach is not feasible for free-ranging populations [36].

Conclusion

Chronic wasting disease represents a persistent and expanding threat to cervid populations worldwide. The unique biology of prions, including environmental stability and strain diversity, complicates diagnosis and control. Advances in diagnostic technologies, particularly RT-QuIC, have improved antemortem detection and surveillance capacity. Integrated management strategies combining active surveillance, population reduction, and movement controls are essential to mitigate the impact of CWD. Continued research into prion pathogenesis, host genetics, and environmental decontamination will inform future interventions.

References

[1] Prusiner SB. Prions. Proc Natl Acad Sci USA. 1998;95(23):13363-13383.

[2] Sigurdson CJ, Aguzzi A. Chronic wasting disease. Biochim Biophys Acta. 2007;1772(6):610-618.

[3] Williams ES, Young S. Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildl Dis. 1980;16(1):89-98.

[4] Benestad SL, Mitchell G, Simmons M, et al. First case of chronic wasting disease in Europe in a Norwegian free-ranging reindeer. Vet Res. 2016;47(1):88.

[5] Caughey B, Baron GS, Chesebro B, et al. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem. 2009;78:177-204.

[6] Cobb NJ, Surewicz WK. Prion diseases and their biochemical mechanisms. Biochemistry. 2009;48(12):2574-2585.

[7] Jarrett JT, Lansbury PT. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell. 1993;73(6):1055-1058.

[8] Knowles TP, Waudby CA, Devlin GL, et al. An analytical solution to the kinetics of breakable filament assembly. Science. 2009;326(5959):1533-1537.

[9] Angers RC, Kang HE, Napier D, et al. Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science. 2010;328(5982):1154-1158.

[10] Perrott MR, Sigurdson CJ, Mason GL, et al. Evidence for distinct chronic wasting disease (CWD) strains in elk and deer. Prion. 2012;6(1):41-48.

[11] O'Rourke KI, Spraker TR, Hamburg LK, et al. Polymorphisms in the prion precursor functional gene but not the pseudogene are associated with susceptibility to chronic wasting disease in white-tailed deer. J Gen Virol. 2004;85(Pt 5):1339-1346.

[12] Jewell JE, Conner MM, Wolfe LL, et al. Low frequency of PrP genotype 225SF among free-ranging mule deer (Odocoileus hemionus) with chronic wasting disease. J Gen Virol. 2005;86(Pt 8):2127-2134.

[13] Williams ES. Chronic wasting disease. Vet Pathol. 2005;42(5):530-549.

[14] Miller MW, Williams ES. Chronic wasting disease in cervids. Rev Sci Tech. 2002;21(1):139-147.

[15] Haley NJ, Hoover EA. Chronic wasting disease of cervids: current knowledge and future perspectives. Annu Rev Anim Biosci. 2015;3:305-325.

[16] Spraker TR, Zink RR, Cummings BA, et al. Distribution of protease-resistant prion protein in the brain of mule deer and Rocky Mountain elk with chronic wasting disease. J Vet Diagn Invest. 2002;14(1):3-12.

[17] Sigurdson CJ, Williams ES, Miller MW, et al. Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). J Gen Virol. 1999;80(Pt 10):2757-2764.

[18] Wolfe LL, Conner MM, Baker TH, et al. Evaluation of antemortem sampling to estimate chronic wasting disease prevalence in free-ranging mule deer. J Wildl Dis. 2007;43(4):623-632.

[19] O'Rourke KI, Baszler TV, Besser TE, et al. Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue. J Clin Microbiol. 2000;38(9):3254-3259.

[20] Hibler CP, Wilson KL, Spraker TR, et al. Field validation and assessment of an enzyme-linked immunosorbent assay for detecting chronic wasting disease in mule deer. J Vet Diagn Invest. 2003;15(2):129-135.

[21] Thomsen BV, Schneider DA, O'Rourke KI, et al. Diagnostic accuracy of two commercial ELISAs for detection of chronic wasting disease in white-tailed deer. J Vet Diagn Invest. 2012;24(1):97-102.

[22] Atarashi R, Satoh K, Sano K, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011;17(2):175-178.

[23] Wilham JM, Orrú CD, Bessen RA, et al. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassay. PLoS Pathog. 2010;6(12):e1001217.

[24] Haley NJ, Siepker C, Hoon-Hanks LL, et al. Seeded amplification of chronic wasting disease prions in nasal brushings and rectal mucosa from deer. J Gen Virol. 2016;97(9):2324-2331.

[25] Davenport KA, Mosher BA, Brost BM, et al. Assessment of chronic wasting disease prion shedding in deer saliva with occupancy modeling. J Clin Microbiol. 2018;56(1):e01243-17.

[26] Race RE, Ernst D, Sutton D, et al. Diagnostic implications of detection of proteinase K-resistant protein in spleen, lymph nodes, and brain of sheep with scrapie. J Am Vet Med Assoc. 1994;204(4):560-565.

[27] Miller MW, Swanson HM, Wolfe LL, et al. Lions and prions and deer demise. PLoS One. 2008;3(12):e4019.

[28] Haley NJ, Siepker C, Walter WD, et al. Antemortem detection of chronic wasting disease prions in nasal brushings and rectal mucosa of white-tailed deer. J Clin Microbiol. 2016;54(7):1692-1698.

[29] Sorensen A, van Beest FM, Brook RK. Impacts of wildlife baiting and supplemental feeding on infectious disease transmission risk: a synthesis of knowledge. Prev Vet Med. 2014;113(4):356-366.

[30] Blanchong JA, Samuel MD, Scribner KT, et al. Landscape genetics and the spatial distribution of chronic wasting disease. Biol Lett. 2008;4(1):130-133.

[31] Wasserberg G, Osnas EE, Rolley RE, et al. Host culling as an adaptive management tool for chronic wasting disease in white-tailed deer: a modelling study. J Appl Ecol. 2009;46(2):457-466.

[32] Manjerovic MB, Green ML, Mateus-Pinilla N, et al. The importance of localized culling in controlling chronic wasting disease in white-tailed deer. J Wildl Dis. 2014;50(1):1-10.

[33] Thompson AK, Samuel MD, Van Deelen TR. Alternative feeding strategies and potential disease transmission in Wisconsin white-tailed deer. J Wildl Manage. 2008;72(2):416-421.

[34] Bartelt-Hunt SL, Bartz JC. Behavior of prions in the environment: implications for prion biology. PLoS Pathog. 2013;9(2):e1003145.

[35] Taylor DM. Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J. 2000;159(1):10-17.

[36] Robinson SJ, Samuel MD, O'Rourke KI, et al. The role of genetics in chronic wasting disease of North American cervids. Prion. 2012;6(2):153-162.

[37] Miller MW, Wild MA, Williams ES. Epidemiology of chronic wasting disease in captive Rocky Mountain elk. J Wildl Dis. 1998;34(3):532-538.

[38] Spraker TR, Miller MW, Williams ES, et al. Spongiform encephalopathy in free-ranging mule deer (Odocoileus hemionus), white-tailed deer (Odocoileus virginianus), and Rocky Mountain elk (Cervus elaphus nelsoni) in northcentral Colorado. J Wildl Dis. 1997;33(1):1-6.

[39] Sigurdson CJ, Spraker TR, Miller MW, et al. PrP(CWD) in the myenteric plexus, vagosympathetic trunk and endocrine glands of deer with chronic wasting disease. J Gen Virol. 2001;82(Pt 10):2327-2334.

[40] Angers RC, Seward TS, Napier D, et al. Chronic wasting disease prions in elk antler velvet. Emerg Infect Dis. 2009;15(5):696-703.

[41] Haley NJ, Mathiason CK, Carver S, et al. Detection of chronic wasting disease prions in salivary, urinary, and intestinal tissues of deer: potential mechanisms of prion shedding and transmission. J Virol. 2011;85(13):6309-6318.

[42] Mathiason CK, Hays SA, Powers J, et al. Infectious prions in pre-clinical deer and transmission of chronic wasting disease solely by environmental exposure. PLoS One. 2009;4(6):e5916.

[43] Miller MW, Williams ES, Hobbs NT, et al. Environmental sources of prion transmission in mule deer. Emerg Infect Dis. 2004;10(6):1003-1006.

[44] Johnson CJ, Phillips KE, Schramm PT, et al. Prions adhere to soil minerals and remain infectious. PLoS Pathog. 2006;2(4):e32.

[45] Saunders SE, Bartelt-Hunt SL, Bartz JC. Occurrence, transmission, and zoonotic potential of chronic wasting disease. Emerg Infect Dis. 2012;18(3):369-376.

[46] Race B, Meade-White K, Race R, et al. Prion infectivity in the urine of mice with chronic wasting disease. J Virol. 2012;86(10):5886-5890.

[47] Tamgüney G, Miller MW, Wolfe LL, et al. Asymptomatic deer excrete infectious prions in faeces. Nature. 2009;461(7263):529-532.

[48] Pulford B, Spraker TR, Wyckoff AC, et al. Detection of PrPCWD in feces from naturally infected Rocky Mountain elk by real-time quaking-induced conversion. J Vet Diagn Invest. 2012;24(5):903-908.

[49] Henderson DM, Davenport KA, Haley NJ, et al. Quantitative assessment of prion infectivity in tissues and body fluids by real-time quaking-induced conversion. J Gen Virol. 2015;96(Pt 1):210-219.

[50] Orrú CD, Groveman BR, Hughson AG, et al. Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. mBio. 2015;6(1):e02451-14.